Fact CheckerSign in

NCT05761210Completed

Characterization of Serum Proteome in Young Obese Subjects (POSING)

Characterization of Serum Proteome in Young Obese Subjects With Different Degrees of Liver Steatosis

Source: ClinicalTrials.gov · Last updated 2 Oct 2024

Brief summary (registry, in English)

With the project proposal we aim to identify serum markers for the characterization of steatosis in subjects affected by essential obesity at a young age. In this case the markers could be useful not only for the development of new diagnostic scores, or for combining them with diagnostic imaging technologies, but also for understanding the metabolic alterations according to the patient's gender, extremely important data in this disease to which only recently has biomedical research started.

Status (registry)
Completed
Study type
Observational
Enrollment
92 (actual)
First submitted
27 Feb 2023
Start date
19 Apr 2022
Primary completion date
1 Oct 2024
Lead sponsor
Istituto Auxologico Italiano
Diseases
Obesity
NCT number
NCT05761210

What you commit to

  • Study type: Observational
  • Participants enrolled: 92
  • From 19 Apr 2022 to the primary completion date, 1 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • \- age \< 13 years and \> 18 years

Who the study is looking for

  • obesity (BMI SDS \> 2)
  • age range: 13-18

Age in the registry: 13 years to 18 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istituto Auxologico Italiano IRCCS, Site Piancavallo
Coordinator of this site? Confirm its status
OggebbioItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.